Ciechanover joins Aurora advisory board

Dr. Aaron Ciechanover, the 2004 Nobel laureate in chemistry, has joined the technology advisory board of dedicated breast MRI technology developer Aurora Imaging Technology of North Andover, Mass.

Ciechanover is a research professor of biochemistry in the Rappaport Faculty of Medicine and Research Institute of the Technion-Israel Institute of Technology in Haifa, Israel.

His research converted intracellular proteolysis into a major research area in modern biology and biomedicine. Ciechanover’s studies led to the understanding of the mechanisms of protein ubiquitination and degradation that initiated the development of a new generation of highly specific mechanism-based drugs, according to Aurora.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.